Ioannis Panagiotelis appointed as Chief Marketing and Sales Officer

August 23, 2017

STOCKHOLM, August 23, 2017 – Elekta (EKTA-B.ST) has appointed Ioannis Panagiotelis as Chief Marketing and Sales Officer (CMSO) with immediate effect following the decision by Chief Commercial Officer, Ian Alexander, to resign.

All Elekta markets will report to the CMSO except China and North America who will report directly to the CEO. Panagiotelis, who joined Elekta earlier this calendar year, will continue to lead Elekta’s global marketing efforts.

Elekta President and CEO, Richard Hausmann, says: “Ioannis is a very talented executive who will speed up the implementation of measures to further our market growth, with special attention to customer satisfaction.”

Richard Hausmann adds: “We are sorry to see Ian Alexander go and wish him all the best in his future endeavors. Ian has led our commercial organization tirelessly for many years and we are grateful for his many contributions to Elekta.”

Elekta’s Executive Management team per September 1, 2017:

Richard Hausmann, President and Chief Executive Officer
Gustaf Salford, Chief Financial Officer
Karin Svenske Nyberg, EVP HR
Maurits Wolleswinkel, Chief Strategy Officer
John Lapré, Chief Technology Officer
Ioannis Panagiotelis, Chief Marketing and Sales Officer
Steven Wort, Chief Operating Officer
Peter Gaccione, EVP Region North America
Anming Gong, EVP Region China
Jonas Bolander, General Counsel and EVP

# # #

For further information, please contact:
Gert van Santen, Elekta Corporate Communications
Tel: +31 653 561 242, e-mail: [email protected]
Time zone: CET: Central European Time

Johan Andersson, Director Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: [email protected]
Time zone: CET: Central European Time

About Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com.

Downloads

Release